48 2. DETERMINATION OF THE IPI MEASURE › 2.3. Union interest › 2.3.1. Interest of Union economic operators, Regulation (EU) 2025/1197

In forcesince 19 Jun 2025

Indeed, it should be recalled that the analysis of the data available in TED shows that the overall value of Union procurement procedures with an estimated value equal to or above EUR 5000000 net of VAT for medical devices, and thus within the scope of the IPI measure, would correspond to around 59 % of the aggregated value of all procurement procedures for medical devices reported in this database for the years 2017 to 2022. As public procurement accounts for 50 % to 70 % of the total Union consumption of medical devices, and there is no reason to consider that the share between public and private procurement would be different for the medical devices originating in the PRC, it can be estimated that, under a conservative scenario, the exclusion of economic operators originating in the PRC from the procurement procedures covered by the IPI measure, coupled with the obligation on successful bidders not to offer, for the duration of the contract, a proportion of medical devices originating in the PRC of a value above 50 % of the total value of the contract, could reduce imports of medical devices originating in the PRC by 15 %–20 % annually [The conservative estimation is based on the following parameters: (i) the value of Union imports of medical devices originating in the PRC (EUR 6,2 billion); (ii) the share of public spending in the Union market of medical devices (ranging between 50 %–70 %); (iii) the estimated share of public procurement procedures for medical devices above the threshold for the application of the IPI measure in total procurement (around 59 %); and (iv) the 50 % origin requirement for the maximum value of medical devices in any procurement procedure above the threshold for the application of the IPI measure.]. That would represent between EUR 1 billion and EUR 1,2 billion annually, out of the EUR 6,2 billion of total imports of medical devices originating in the PRC [The size of the new market opportunities expected for Union manufacturers can only be estimated based on official trade statistics, due to the lack of direct, firm-level data on the overall value of medical devices originating in the PRC that are destined for public procurement in the Union.].